---
figid: PMC10484181__MCO2-4-e359-g004
figtitle: Potential mechanism of P2X7R overexpression causing tumor progression
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC10484181
filename: PMC10484181__MCO2-4-e359-g004.jpg
figlink: /pmc/articles/PMC10484181/figure/F3
number: F3
caption: 'The potential mechanism of P2X7R overexpression causing tumor progression.
  High expression of P2X7R can alter the infiltration of immune cells in TME, creating
  an immunosuppressive microenvironment. At the same time, P2X7R also activates intracellular
  growth promotion pathways such as NFATc1, ERK, Akt, and HIF‐1a. NFATc1: nuclear
  factor‐activated T cell 1; ERK, extracellular regulated protein kinases; Akt, protein
  kinase B; HIF‐1a, hypoxia‐inducible factor‐1α; COX<: cyclooxygenase‐2; MDSC, myeloid‐derived
  suppressor cell; TAM, tumor‐associated macrophages; ARG1, arginase 1; TGF‐β1, transforming
  growth factor‐β1; ROS, reactive oxygen species; IL‐10, interleukin‐10.'
papertitle: Purine and purinergic receptors in health and disease
reftext: Yanling Ai, et al. MedComm (2020). 2023 Oct;4(5):e359.
year: '2023'
doi: 10.1002/mco2.359
journal_title: MedComm
journal_nlm_ta: MedComm (2020)
publisher_name: John Wiley and Sons Inc.
keywords: ATP | cancer | immunity | P2x7 | purinergic | tumor microenvironment
automl_pathway: 0.957816
figid_alias: PMC10484181__F3
figtype: Figure
redirect_from: /figures/PMC10484181__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10484181__MCO2-4-e359-g004.html
  '@type': Dataset
  description: 'The potential mechanism of P2X7R overexpression causing tumor progression.
    High expression of P2X7R can alter the infiltration of immune cells in TME, creating
    an immunosuppressive microenvironment. At the same time, P2X7R also activates
    intracellular growth promotion pathways such as NFATc1, ERK, Akt, and HIF‐1a.
    NFATc1: nuclear factor‐activated T cell 1; ERK, extracellular regulated protein
    kinases; Akt, protein kinase B; HIF‐1a, hypoxia‐inducible factor‐1α; COX<: cyclooxygenase‐2;
    MDSC, myeloid‐derived suppressor cell; TAM, tumor‐associated macrophages; ARG1,
    arginase 1; TGF‐β1, transforming growth factor‐β1; ROS, reactive oxygen species;
    IL‐10, interleukin‐10.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ATP8A2
  - NFATC1
  - AKT1
  - AKT2
  - AKT3
  - COX8A
  - CPOX
  - COX5A
  - COX5B
  - COX6C
  - COX7C
  - .na.character
  - COX4I1
  - COX4I2
  - COX6A1
  - COX6A2
  - COX6B1
  - COX6B2
  - COX7A1
  - COX7A2
  - COX7B
  - COX7B2
  - COX8C
  - COX2
  - PTGS2
  - MTCO2P12
  - ARG1
  - TINAGL1
  - EPHB2
  - MAPK1
  - MAPK3
  - HIF1A
  - TGFB1
  - CXCL10
  - CXCL11
  - CXCL12
  - CXCL13
  - CXCL14
  - CXCL9
  - PF4
  - CXCL1
  - CXCL2
  - CXCL3
  - CXCL5
  - CXCL6
  - CXCL8
  - PPBP
  - IL10
  - TAM
  - STIM1
  - ATP
  - Ca2+
  - ROS
  - Cancer
---
